TMO logo
Thermo Fisher Scientific Inc.
TMO
412.06 (1.76%) 7.26
155.55(B)
Health Care
Life Sciences Tools and Services
Thermo Fisher Scientific Inc. provides life sciences solutions analytical instruments specialty diagnostics and laboratory products and biopharma services in the North America Europe Asia-Pacific and internationally. The company’s Life Sciences Solutions segment offers reagents instruments and consumables for biological and medical research discovery and production of drugs and vaccines as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments consumables software and services for pharmaceutical biotechnology academic government environmental and other research and industrial markets as well as clinical laboratories. The company’s Specialty Diagnostics segment includes clinical diagnostics offering liquid ready-to-use and lyophilized immunodiagnostic reagent kits as well as calibrators controls protein detection assays and instruments; immunodiagnostics offers develops manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy asthma and autoimmune diseases; microbiology offers dehydrated and prepared culture media collection and transport systems instrumentation and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables diagnostic kits and reagents equipment instruments solutions and services. Its Laboratory Products and Biopharma Services segment provides laboratory products research and safety market channel and pharma services and clinical research. It offers products and services through a direct sales force customer-service professionals electronic commerce and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham Massachusetts.
My Holdings:
(?% ownership)
Shares:
Cost basis:
Market cap:$155.55(B)
EV:$183.96(B)
Total Equity:$49.48(B)
Div. yield:0.39%
P/S:3.66
P/E:24.10
P/FCF:23.14
P/B:3.15
EPS:$17.1
FCF/share:$17.8
Dividend/share:$1.6
Book value/share:$130.8
ROIC:7.9%
ROA:6.6%
ROE:13.7%

TMO Valuation

  Current Price
412.06
PE Valuation
N/A
Analyst targets
N/A
DCF
N/A
DCF (exit mult.)
N/A
Future P/E
N/A
Peter Lynch FV
N/A
Graham No.
N/A
DDM
N/A

Using the PEvaluation method, the intrinsic value estimate of TMO is $359.6.
At the current price of 412.1, TMO is 13% overvalued.

Based on 0 valuation methods, the average fair value estimate for TMO is $N/A (NaN% overvalued).

Valuations range from $1.7976931348623157e+308 (N/A) to $0.0 (N/A).

PEvaluation

13% overvalued
Low
$270
Mid
$360
High
$449
Current price
$412
Fair P/E
Margin of safety
Shares outstan...ROICRevenue growthDebt/FCFAssets/Liabili...
Economic moat: Medium

Analyst Price Targets

38% undervalued
Low
$475
Mid
$568
High
$767
Current price
$412
Strong Buy7
Buy18
Hold6
Sell0
Strong Sell0

Estimated EPS

LowAvgHigh#
FY+122.022.524.629
FY+223.924.827.229
FY+325.727.729.818
FY+429.430.731.94
FY+532.033.033.92

Discounted Cash Flow

Forecast years
Terminal Growth Rate
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Discounted Cash Flow (exit mult.)

Forecast years
Exit FCF Multiple
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Future P/E Valuation

Projection Years
Base Revenue
Revenue Growth Rate
Final Net Margin
Final P/E Ratio
Discount Rate

Peter Lynch Fair Value

Earnings Per Share
Growth Rate (*)

(*) Growth rate is capped between 5 and 25

Graham Formula

Earnings Per Share
Expected Growth Rate
Government Bond Rate

Dividend Discount Model

Annual Dividend
First Stage Length (Years)
First Stage Growth Rate
Final Growth Rate
Discount Rate

(*) First stage rowth rate is capped to 20%

TTM Financials

Income (TTM)

RevenueGrossNet
Revenue$42.90(B)
Gross profit$17.77(B)
EBITDA$10.83(B)
Net income$6.51(B)
Gross margin41.4%
Operating margin18.3%
Net margin15.2%
Shares outstanding:377.49(M)

Balance sheet

Cash & ST inv.Other ST assetsLong term assetsCurrent liabilitiesLong term debtOther LT liabilitiesEquity
Total assets$99.04(B)
Current assets$23.38(B)
Total liabilities$49.56(B)
Current liabilities$13.17(B)
Cash & Short-term inv.$5.95(B)
Long-term debt$31.24(B)
Total intangibles$61.82(B)
PP&E$9.33(B)

Cash flow (TTM)

CFOCFICFF
FCF$6.72(B)
CapEx$-1.42(B)
Dividends paid$-597.00(M)
Stock issued$0
Stock repurchased$-3.00(B)
Stock-based comp.$306.00(M)
Debt issued$2.84(B)
Debt repaid$-4.45(B)

Per share data

Price: $412
Revenue: $113 (3.7x | 27.3%) Gross profit: $47.1 (8.8x | 11.4%) Earnings: $17.1 (24.1x | 4.1%)
FCF: $17.8 (23.1x | 4.3%) Stock-based Comp.: $0.81 (508.3x | 0.2%) Dividend: $1.60 (257.5x | 0.4%)
Total Assets: $262 (1.6x | 63.7%) Total Liabilities: $131 (3.1x | 31.9%) Book Value: $131 (3.1x | 31.8%) Cash & ST inv.: $15.8 (26.2x | 3.8%) Debt: $82.8 (5.0x | 20.1%)

Growth Estimates

Revenue

CAGR: 5.6%
FY+1FY+2FY+3FY+4FY+5
FY+1$43.68(B)
FY+2(+6.2%)$46.41(B)
FY+3(+6.8%)$49.56(B)
FY+4(+5.5%)$52.29(B)
FY+5(+3.9%)$54.31(B)

Net Income

CAGR: 9.4%
FY+1FY+2FY+3FY+4FY+5
FY+1$8.48(B)
FY+2(+9.8%)$9.31(B)
FY+3(+9.9%)$10.23(B)
FY+4(+10.0%)$11.26(B)
FY+5(+7.8%)$12.13(B)

EPS

CAGR: 10.1%
FY+1FY+2FY+3FY+4FY+5
FY+1$22.47
FY+2(+10.5%)$24.84
FY+3(+11.6%)$27.73
FY+4(+10.8%)$30.73
FY+5(+7.3%)$32.98

FCF per share

CAGR: 13.4%
FY+1FY+2FY+3
FY+1$22.50
FY+2(+18.0%)$26.55
FY+3(+8.9%)$28.91

Historical Financials

Showing limited histrical data. Access 10+ years of financials now! Upgrade
YearlyQuarterly
Income
FY2005FY2006FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
FY2005FY2006FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024TTM5Y avg5Y CAGR
Revenue32.22(B)39.21(B)44.91(B)42.86(B)42.88(B)42.90(B)40.42(B)7%
COGS16.21(B)19.57(B)25.94(B)25.76(B)25.18(B)25.09(B)22.53(B)12%
Gross Profit16.00(B)19.64(B)18.97(B)17.10(B)17.70(B)17.80(B)17.88(B)3%
Total OpEx.8.11(B)9.41(B)10.46(B)9.78(B)9.98(B)9.96(B)9.55(B)5%
  R&D1.18(B)1.41(B)1.47(B)1.34(B)1.39(B)1.40(B)1.36(B)4%
  SG&A6.93(B)8.01(B)8.99(B)8.45(B)8.60(B)8.13(B)8.19(B)6%
Operating Income7.89(B)10.22(B)8.51(B)7.32(B)7.72(B)7.84(B)8.33(B)-1%
Interest Expense-553.00(M)-536.00(M)-726.00(M)-1.38(B)-1.39(B)-1.33(B)-916.00(M)26%
Interest Income65.00(M)43.00(M)272.00(M)879.00(M)1.08(B)1.00(B)467.40(M)102%
Pre-tax income7.23(B)8.84(B)7.83(B)6.30(B)7.04(B)7.07(B)7.45(B)-1%
Income tax-850.00(M)-1.11(B)-703.00(M)-284.00(M)-657.00(M)-472.00(M)-720.60(M)-6%
Net Income6.38(B)7.72(B)6.95(B)6.00(B)6.33(B)6.51(B)6.68(B)-0%
Cash flow
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Stock-based Comp.FCFCFONet IncomeD&ACFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Total AssetsTotal LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EIntangible AssetsGoodwillCurrent liabilitiesAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Per share data
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
EPS (Basic)FCF/ShareDividend/ShareEPS (Diluted)Book value/ShareCash & ST inv./ShareDebt/Share
Ratios
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
P/EP/SEV/EarningsP/FCFP/BEV/FCFDebt/EquityPayout ratio
Margins
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Net Income MarginOperating MarginGross MarginEBITDA MarginFCF Margin
Returns
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
ROICROAROCEROE
Shares outstanding
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Shares (Basic)Shares (Diluted)
Market Cap.
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Market Cap.

Similar Companies

Ownership

Major holders

Insiders: 0.18%
Institutions: 92.58%
Other: 7.24%

Institutional ownership

8.81% Vanguard Group Inc7.64% Blackrock Inc.4.36% State Street Corporati...3.04% Morgan Stanley2.89% Price (T.Rowe) Associa...2.50% Capital World Investor...2.36% JPMORGAN CHASE & CO2.10% Capital Research Globa...2.08% Geode Capital Manageme...1.68% FMR, LLC55.12% Others

Insider transactions

Show:
Buys
Sells
Grants
DateSharesTotal ($)Price ($)NameTitle
Sell2025-04-28300128,979429.9PETTITI GIANLUCAOfficer
Sell2025-03-103,7752,010,537532.6BOXER MICHAEL AGeneral Counsel
Grant2025-03-0518,0004,571,820254.0CASPER MARC NChief Executive Officer
Sell2025-03-0518,0009,326,854518.2CASPER MARC NChief Executive Officer
Sell2025-03-031,780945,038530.9SHAFER MICHAEL DOfficer
Grant2025-02-2418,3003,855,444210.7LOWERY FREDERICK M.Officer
Sell2025-02-2418,3009,732,123531.8LOWERY FREDERICK M.Officer
Grant2025-02-196,68100.0LOWERY FREDERICK M.Officer
Grant2025-02-198,87900.0PETTITI GIANLUCAOfficer
Grant2025-02-1963100.0HOLMES JOSEPH R.Officer
Grant2025-02-196,31500.0SHAFER MICHAEL DOfficer
Grant2025-02-193,48200.0BRITT LISA POfficer
Grant2025-02-192,61100.0BOXER MICHAEL AGeneral Counsel
Grant2025-02-199,64900.0LAGARDE MICHELChief Operating Officer
Grant2025-02-197,94200.0WILLIAMSON STEPHENChief Financial Officer
Grant2025-02-1923,73600.0CASPER MARC NChief Executive Officer
Grant2025-02-199500.0LYNCH KAREN S.Director
Sell2025-02-19168,449528.1CHAI NELSON JDirector
Grant2025-02-142,75000.0CASPER MARC NChief Executive Officer
Grant2025-02-0419,6504,990,904254.0WILLIAMSON STEPHENChief Financial Officer
Sell2025-02-04300175,677585.6PETTITI GIANLUCAOfficer
Sell2025-02-0419,65011,580,924589.4WILLIAMSON STEPHENChief Financial Officer
Buy2024-12-092011,038551.9CHAI NELSON JDirector
Grant2024-12-0519000.0BOXER MICHAEL AGeneral Counsel
Sell2024-12-0320,00010,624,559531.2CASPER MARC NChief Executive Officer
Sell2024-11-089,0004,975,765552.9CASPER MARC NChief Executive Officer
Sell2024-11-0720,00011,158,768557.9CASPER MARC NChief Executive Officer
Grant2024-11-015,8501,232,478210.7CASPER MARC NChief Executive Officer
Sell2024-11-015,8503,263,668557.9CASPER MARC NChief Executive Officer
Grant2024-10-3120,0004,213,600210.7CASPER MARC NChief Executive Officer
Sell2024-10-3120,00011,010,295550.5CASPER MARC NChief Executive Officer
Grant2024-10-2920,0004,213,600210.7CASPER MARC NChief Executive Officer
Sell2024-10-2920,00011,049,123552.5CASPER MARC NChief Executive Officer
Grant2024-10-252,000421,360210.7BOXER MICHAEL AGeneral Counsel
Sell2024-10-25300168,048560.2PETTITI GIANLUCAOfficer
Sell2024-10-252,0001,120,320560.2BOXER MICHAEL AGeneral Counsel
Grant2024-09-0420,0004,213,600210.7CASPER MARC NChief Executive Officer
Sell2024-09-0420,00012,168,974608.4CASPER MARC NChief Executive Officer
Grant2024-07-3110,0002,106,800210.7CASPER MARC NChief Executive Officer
Sell2024-07-3110,0006,172,098617.2CASPER MARC NChief Executive Officer
Grant2024-07-3016,3003,307,517202.9CASPER MARC NChief Executive Officer
Sell2024-07-3016,3009,879,804606.1CASPER MARC NChief Executive Officer
Grant2024-07-262,000421,360210.7BOXER MICHAEL AGeneral Counsel
Grant2024-07-26860197,859230.1HOLMES JOSEPH R.Officer
Sell2024-07-26300180,255600.9PETTITI GIANLUCAOfficer
Sell2024-07-26860525,484611.0HOLMES JOSEPH R.Officer
Sell2024-07-263,6242,221,582613.0BRITT LISA POfficer
Sell2024-07-262,0001,201,700600.9BOXER MICHAEL AGeneral Counsel
Grant2024-06-0420,0003,811,800190.6CASPER MARC NChief Executive Officer
Sell2024-06-0420,00011,374,358568.7CASPER MARC NChief Executive Officer
Grant2024-05-281,11200.0WILLIAMSON STEPHENChief Financial Officer
Grant2024-05-2233900.0SPERLING SCOTT MDirector
Grant2024-05-2233900.0CHANDY RUBY RDirector
Grant2024-05-2233900.0KEITH R ALEXANDRADirector
Grant2024-05-2233900.0HARRIS C. MARTIN M.D.Director
Grant2024-05-2233900.0JACKS TYLERDirector
Grant2024-05-2233900.0SPAR DEBORA LDirector
Grant2024-05-2233900.0WEISLER DION JDirector
Grant2024-05-2233900.0CHAI NELSON JDirector
Grant2024-05-2233900.0MULLEN JAMES CHARLESDirector
Grant2024-05-2233900.0JOHNSON JENNIFER MDirector
Grant2024-05-1415,97100.0WILLIAMSON STEPHENChief Financial Officer
Grant2024-05-1420,0002,103,400105.2LAGARDE MICHELChief Operating Officer
Sell2024-05-1420,00011,801,000590.0LAGARDE MICHELChief Operating Officer
Grant2024-05-1321,9254,619,159210.7WILLIAMSON STEPHENChief Financial Officer
Sell2024-05-1321,92512,963,595591.3WILLIAMSON STEPHENChief Financial Officer

Tools

Dividend Income

Investment Amount
Dividend Yield
What is the Dividend Income Calculator?

The Dividend Income Calculator helps you estimate the yearly, quarterly, monthly, and daily income of your investments.

How to Use This Calculator?

Enter the dividend yield and the invested amount. Optionally, preload stock data to automatically fetch the dividend yield.

Required Investment

Dividend Yield
Desired Yearly Payout
Desired Quarterly Payout
Desired Monthly Payout
What is the Required Investment Calculator?

The Required Investment Calculator helps you determine the amount of money you need to invest in a stock to achieve a desired dividend.

How to Use This Calculator?

Enter the dividend yield and your desired dividend income. Optionally, preload stock data to automatically fetch the dividend yield.

Future Dividend Yield

Base Dividend
Current Price
Number of Years
Dividend Growth Rate
What is the Future Yield Calculator?

The Future Yield Calculator helps you estimate the future dividend yield of a stock based on its current dividend, price, and expected dividend growth rate.

How to Use This Calculator?

Enter the base dividend, current price, number of years, and dividend growth rate. Optionally, preload stock data to automatically fetch the dividend and price. The calculator will display the current yield and the projected future yield.